2Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesteroll in Adults. Executive Summarry of the third report of the national cholesterol education program (NCEP) Expert panel on DEtection, and Treatment of High Blood Cholesterol in Adults. ( Adult Treatment Panel Ⅲ) [J]. JAMA, 2001, 285: 2486-2497.
6Schwartz GG,Olsson AG,EzekowitzMD,et al. Effects of atorvas tatin on early recurrent ischemic events in acute coronary syn dromes:The MIRACL study: A randomized controlled trial [J].JAMA,2001,285(13):1711 -1718.
7Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins alter acute coronary syndromes[J]. N Engl J Med, 2004, :350 (15) : 1495 - 1504.
8Pederson JR, Olsson AG, Faergemen V, et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the scandinavian Simvastatin Sarvival Studu (4s) [J].Circulation, 1998,97:1453- 1460.
9Flaker GC, Warnica JW, Sacks FM, et al. For the cholesterol and Recueht Event ( CARE ) investigators. Pravastain prevents clinical events in revascularized patients with average cholesterol eoncentrations[J].J Am Coll Cardiol, 1999,34 : 106 - 112.
10Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Longterm Intervention with Pravastatin in Isehemie Disease(LIPID)study group[J].N Engl J Med, 1998, 339:1349 - 1357.
